世界のがん焼灼療法機器市場予測（～2028年）：冷凍アブレーション、高密度焦点式超音波（HIFU）、レーザー間質性温熱療法（LiTT）、マイクロ波アブレーション（MWA）、ラジオ波アブレーション（RFA）、非可逆的エレクトロポレーション（Ire）、非熱的アブレーション

• 英文タイトル：Global Cancer Ablation Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E7679 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

がん焼灼療法機器市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のがん焼灼療法機器の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 がん焼灼療法機器市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・冷凍アブレーション、高密度焦点式超音波（HIFU）、レーザー間質性温熱療法（LiTT）、マイクロ波アブレーション（MWA）、ラジオ波アブレーション（RFA）、非可逆的エレクトロポレーション（Ire）、非熱的アブレーション 用途別セグメントは次のように区分されます。 ・脳がん、褐色、結腸直腸がん、腎臓がん、肝臓がん、肺がん、膵臓がん、前立腺がん 世界のがん焼灼療法機器市場の主要な市場プレーヤーは以下のとおりです。 ・Alfresa Pharma Corp.、AngioDynamics, Inc.、BTG plc (Galil Medical Ltd./Perseon Medical)、Biomedical S.r.l.、Boston Scientific Corporation、CSA Medical, Inc.、Chongqing Haifu Medical Technology Co., Ltd、ECO Medical、EDAP TMS S.A.、HS Hospital Service S.p.A.、IceCure Medical, Inc.、Johnson & Johnson (Ethicon, Inc.)、Kang-Yu Medical Co., Ltd.、MedLink Technologies LLC、MedWaves, Inc. 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、がん焼灼療法機器製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要ながん焼灼療法機器メーカーの企業概要、2019年～2022年までのがん焼灼療法機器の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要ながん焼灼療法機器メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別がん焼灼療法機器の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのがん焼灼療法機器の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのがん焼灼療法機器市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびがん焼灼療法機器の産業チェーンを掲載しています。 ・第13、14、15章では、がん焼灼療法機器の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Alfresa Pharma Corp.、AngioDynamics, Inc.、BTG plc (Galil Medical Ltd./Perseon Medical)、Biomedical S.r.l.、Boston Scientific Corporation、CSA Medical, Inc.、Chongqing Haifu Medical Technology Co., Ltd、ECO Medical、EDAP TMS S.A.、HS Hospital Service S.p.A.、IceCure Medical, Inc.、Johnson & Johnson (Ethicon, Inc.)、Kang-Yu Medical Co., Ltd.、MedLink Technologies LLC、MedWaves, Inc. ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：冷凍アブレーション、高密度焦点式超音波（HIFU）、レーザー間質性温熱療法（LiTT）、マイクロ波アブレーション（MWA）、ラジオ波アブレーション（RFA）、非可逆的エレクトロポレーション（Ire）、非熱的アブレーション ・用途別分析2017年-2028年：脳がん、褐色、結腸直腸がん、腎臓がん、肝臓がん、肺がん、膵臓がん、前立腺がん ・がん焼灼療法機器の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・がん焼灼療法機器のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・がん焼灼療法機器のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・がん焼灼療法機器の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・がん焼灼療法機器の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Cancer Ablation Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cancer Ablation Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Brain Cancer accounting for % of the Cancer Ablation Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cryoablation segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Cancer Ablation Devices include Alfresa Pharma Corp., AngioDynamics, Inc., BTG plc (Galil Medical Ltd./Perseon Medical), Biomedical S.r.l., and Boston Scientific Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cancer Ablation Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cryoablation
High-Intensity Focused Ultrasound (HIFU)
Laser Interstitial Thermal Therapy (LiTT)
Microwave Ablation (MWA)
Radiofrequency Ablation (RFA)
Irreversible Electroporation (Ire)
Non-Thermal Ablation
Market segment by Application can be divided into
Brain Cancer
Brown
Colorectal Cancer
Kidney Cancer
Liver Cancer
Lung Cancer
Pancreatic Cancer
Prostate Cancer
The key market players for global Cancer Ablation Devices market are listed below:
Alfresa Pharma Corp.
AngioDynamics, Inc.
BTG plc (Galil Medical Ltd./Perseon Medical)
Biomedical S.r.l.
Boston Scientific Corporation
CSA Medical, Inc.
Chongqing Haifu Medical Technology Co., Ltd
ECO Medical
EDAP TMS S.A.
HS Hospital Service S.p.A.
IceCure Medical, Inc.
Johnson & Johnson (Ethicon, Inc.)
Kang-Yu Medical Co., Ltd.
MedLink Technologies LLC
MedWaves, Inc.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Ablation Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Ablation Devices, with price, sales, revenue and global market share of Cancer Ablation Devices from 2019 to 2022.
Chapter 3, the Cancer Ablation Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Ablation Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Ablation Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Ablation Devices.
Chapter 13, 14, and 15, to describe Cancer Ablation Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Cancer Ablation Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cancer Ablation Devices Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Cryoablation
1.2.3 High-Intensity Focused Ultrasound (HIFU)
1.2.4 Laser Interstitial Thermal Therapy (LiTT)
1.2.5 Microwave Ablation (MWA)
1.2.6 Radiofrequency Ablation (RFA)
1.2.7 Irreversible Electroporation (Ire)
1.2.8 Non-Thermal Ablation
1.3 Market Analysis by Application
1.3.1 Overview: Global Cancer Ablation Devices Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Brain Cancer
1.3.3 Brown
1.3.4 Colorectal Cancer
1.3.5 Kidney Cancer
1.3.6 Liver Cancer
1.3.7 Lung Cancer
1.3.8 Pancreatic Cancer
1.3.9 Prostate Cancer
1.4 Global Cancer Ablation Devices Market Size & Forecast
1.4.1 Global Cancer Ablation Devices Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Cancer Ablation Devices Sales in Volume (2017-2028)
1.4.3 Global Cancer Ablation Devices Price (2017-2028)
1.5 Global Cancer Ablation Devices Production Capacity Analysis
1.5.1 Global Cancer Ablation Devices Total Production Capacity (2017-2028)
1.5.2 Global Cancer Ablation Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Ablation Devices Market Drivers
1.6.2 Cancer Ablation Devices Market Restraints
1.6.3 Cancer Ablation Devices Trends Analysis
2 Manufacturers Profiles
2.1 Alfresa Pharma Corp.
2.1.1 Alfresa Pharma Corp. Details
2.1.2 Alfresa Pharma Corp. Major Business
2.1.3 Alfresa Pharma Corp. Cancer Ablation Devices Product and Services
2.1.4 Alfresa Pharma Corp. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AngioDynamics, Inc.
2.2.1 AngioDynamics, Inc. Details
2.2.2 AngioDynamics, Inc. Major Business
2.2.3 AngioDynamics, Inc. Cancer Ablation Devices Product and Services
2.2.4 AngioDynamics, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 BTG plc (Galil Medical Ltd./Perseon Medical)
2.3.1 BTG plc (Galil Medical Ltd./Perseon Medical) Details
2.3.2 BTG plc (Galil Medical Ltd./Perseon Medical) Major Business
2.3.3 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Product and Services
2.3.4 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Biomedical S.r.l.
2.4.1 Biomedical S.r.l. Details
2.4.2 Biomedical S.r.l. Major Business
2.4.3 Biomedical S.r.l. Cancer Ablation Devices Product and Services
2.4.4 Biomedical S.r.l. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Boston Scientific Corporation
2.5.1 Boston Scientific Corporation Details
2.5.2 Boston Scientific Corporation Major Business
2.5.3 Boston Scientific Corporation Cancer Ablation Devices Product and Services
2.5.4 Boston Scientific Corporation Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 CSA Medical, Inc.
2.6.1 CSA Medical, Inc. Details
2.6.2 CSA Medical, Inc. Major Business
2.6.3 CSA Medical, Inc. Cancer Ablation Devices Product and Services
2.6.4 CSA Medical, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Chongqing Haifu Medical Technology Co., Ltd
2.7.1 Chongqing Haifu Medical Technology Co., Ltd Details
2.7.2 Chongqing Haifu Medical Technology Co., Ltd Major Business
2.7.3 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Product and Services
2.7.4 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 ECO Medical
2.8.1 ECO Medical Details
2.8.2 ECO Medical Major Business
2.8.3 ECO Medical Cancer Ablation Devices Product and Services
2.8.4 ECO Medical Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 EDAP TMS S.A.
2.9.1 EDAP TMS S.A. Details
2.9.2 EDAP TMS S.A. Major Business
2.9.3 EDAP TMS S.A. Cancer Ablation Devices Product and Services
2.9.4 EDAP TMS S.A. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 HS Hospital Service S.p.A.
2.10.1 HS Hospital Service S.p.A. Details
2.10.2 HS Hospital Service S.p.A. Major Business
2.10.3 HS Hospital Service S.p.A. Cancer Ablation Devices Product and Services
2.10.4 HS Hospital Service S.p.A. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 IceCure Medical, Inc.
2.11.1 IceCure Medical, Inc. Details
2.11.2 IceCure Medical, Inc. Major Business
2.11.3 IceCure Medical, Inc. Cancer Ablation Devices Product and Services
2.11.4 IceCure Medical, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Johnson & Johnson (Ethicon, Inc.)
2.12.1 Johnson & Johnson (Ethicon, Inc.) Details
2.12.2 Johnson & Johnson (Ethicon, Inc.) Major Business
2.12.3 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Product and Services
2.12.4 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Kang-Yu Medical Co., Ltd.
2.13.1 Kang-Yu Medical Co., Ltd. Details
2.13.2 Kang-Yu Medical Co., Ltd. Major Business
2.13.3 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Product and Services
2.13.4 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 MedLink Technologies LLC
2.14.1 MedLink Technologies LLC Details
2.14.2 MedLink Technologies LLC Major Business
2.14.3 MedLink Technologies LLC Cancer Ablation Devices Product and Services
2.14.4 MedLink Technologies LLC Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 MedWaves, Inc.
2.15.1 MedWaves, Inc. Details
2.15.2 MedWaves, Inc. Major Business
2.15.3 MedWaves, Inc. Cancer Ablation Devices Product and Services
2.15.4 MedWaves, Inc. Cancer Ablation Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Cancer Ablation Devices Breakdown Data by Manufacturer
3.1 Global Cancer Ablation Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Cancer Ablation Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Cancer Ablation Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Cancer Ablation Devices Manufacturer Market Share in 2021
3.4.2 Top 6 Cancer Ablation Devices Manufacturer Market Share in 2021
3.5 Global Cancer Ablation Devices Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Cancer Ablation Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cancer Ablation Devices Market Size by Region
4.1.1 Global Cancer Ablation Devices Sales in Volume by Region (2017-2028)
4.1.2 Global Cancer Ablation Devices Revenue by Region (2017-2028)
4.2 North America Cancer Ablation Devices Revenue (2017-2028)
4.3 Europe Cancer Ablation Devices Revenue (2017-2028)
4.4 Asia-Pacific Cancer Ablation Devices Revenue (2017-2028)
4.5 South America Cancer Ablation Devices Revenue (2017-2028)
4.6 Middle East and Africa Cancer Ablation Devices Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Cancer Ablation Devices Sales in Volume by Type (2017-2028)
5.2 Global Cancer Ablation Devices Revenue by Type (2017-2028)
5.3 Global Cancer Ablation Devices Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Cancer Ablation Devices Sales in Volume by Application (2017-2028)
6.2 Global Cancer Ablation Devices Revenue by Application (2017-2028)
6.3 Global Cancer Ablation Devices Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Cancer Ablation Devices Sales by Type (2017-2028)
7.2 North America Cancer Ablation Devices Sales by Application (2017-2028)
7.3 North America Cancer Ablation Devices Market Size by Country
7.3.1 North America Cancer Ablation Devices Sales in Volume by Country (2017-2028)
7.3.2 North America Cancer Ablation Devices Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Cancer Ablation Devices Sales by Type (2017-2028)
8.2 Europe Cancer Ablation Devices Sales by Application (2017-2028)
8.3 Europe Cancer Ablation Devices Market Size by Country
8.3.1 Europe Cancer Ablation Devices Sales in Volume by Country (2017-2028)
8.3.2 Europe Cancer Ablation Devices Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Cancer Ablation Devices Sales by Type (2017-2028)
9.2 Asia-Pacific Cancer Ablation Devices Sales by Application (2017-2028)
9.3 Asia-Pacific Cancer Ablation Devices Market Size by Region
9.3.1 Asia-Pacific Cancer Ablation Devices Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Cancer Ablation Devices Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Cancer Ablation Devices Sales by Type (2017-2028)
10.2 South America Cancer Ablation Devices Sales by Application (2017-2028)
10.3 South America Cancer Ablation Devices Market Size by Country
10.3.1 South America Cancer Ablation Devices Sales in Volume by Country (2017-2028)
10.3.2 South America Cancer Ablation Devices Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cancer Ablation Devices Sales by Type (2017-2028)
11.2 Middle East & Africa Cancer Ablation Devices Sales by Application (2017-2028)
11.3 Middle East & Africa Cancer Ablation Devices Market Size by Country
11.3.1 Middle East & Africa Cancer Ablation Devices Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Cancer Ablation Devices Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Cancer Ablation Devices and Key Manufacturers
12.2 Manufacturing Costs Percentage of Cancer Ablation Devices
12.3 Cancer Ablation Devices Production Process
12.4 Cancer Ablation Devices Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Cancer Ablation Devices Typical Distributors
13.3 Cancer Ablation Devices Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---